Is Farbe Firma WHO-GMP certified?

Yes. Farbe Firma Pvt Ltd is WHO-GMP certified, ISO 9001:2015 compliant, and operates a USFDA-aligned sterile injectable facility in Ankleshwar, Gujarat, India.

Do you provide CTD and ACTD dossier support for export markets?

Yes. We provide complete CTD/ACTD dossiers and product registration support for buyers across 30+ countries in Latin America, CIS, Africa, the Middle East, and South-East Asia.

Why Farbe Firma is the Top Manufacturer of Dexamethasone Sodium Phosphate Injection

Maulik Sudani
3 hours ago
5 min read

Last Updated: May 13, 2026

TL;DR: Dexamethasone Sodium Phosphate Injection is a critical corticosteroid used worldwide for severe inflammation, allergic reactions, cerebral oedema, and acute respiratory distress — and Farbe Firma manufactures it under WHO-GMP certified ISO Class 5 cleanrooms in Gujarat, India, with full CTD/ACTD dossier support for export to 30+ countries.

Key Takeaways

Dexamethasone Sodium Phosphate Injection is a high-potency corticosteroid indispensable in emergency, critical care, oncology supportive therapy, and ophthalmology.
Farbe Firma produces Dexamethasone injection under WHO-GMP, ISO 9001:2015, and ISO Class 5 aseptic conditions, with sterility, endotoxin, and assay testing on every batch.
Available as 4 mg/mL and 8 mg/2 mL sterile solutions in amber glass ampoules and vials to protect light-sensitive API.
Buyers receive CTD/ACTD dossiers, stability data, BMR/BPR, and country-specific registration support across Latin America, CIS, Africa, MENA, and Southeast Asia.

Introduction

Dexamethasone Sodium Phosphate Injection is one of the most widely prescribed corticosteroid injectables in modern medicine. From managing severe asthma exacerbations and anaphylaxis to reducing cerebral oedema in neurological emergencies and supporting oncology patients through chemotherapy-induced nausea, dexamethasone's clinical versatility makes it a hospital essential. The injectable form is critical when oral therapy is impractical, when rapid systemic action is required, or when post-operative inflammation must be controlled.

Sourcing Dexamethasone Sodium Phosphate Injection from a trusted manufacturer is therefore a matter of patient safety, regulatory compliance, and supply continuity. Buyers — whether government tender authorities, hospital procurement chains, or pharma distributors — need a partner with documented WHO-GMP certification, validated aseptic processing, light-protective primary packaging, and the regulatory infrastructure to register the product across multiple markets. Farbe Firma Pvt Ltd, headquartered in Gujarat, India, is exactly that partner.

Understanding Dexamethasone Sodium Phosphate Injection

Dexamethasone Sodium Phosphate is a synthetic glucocorticoid that suppresses inflammation and modulates the immune response. The sodium phosphate ester is the water-soluble salt used in injectable formulations, allowing rapid onset of action through intravenous, intramuscular, intra-articular, or local infiltration routes. The injection is dosed in milligram quantities of dexamethasone base equivalent — most commonly 4 mg/mL or 8 mg/2 mL strengths — and is included on the WHO Model List of Essential Medicines.

Clinical applications span allergic emergencies, cerebral oedema, septic shock-related adrenal insufficiency, severe asthma, croup in pediatrics, antiemetic prophylaxis in oncology, and the management of moderate-to-severe COVID-19 cases requiring oxygen — an indication where dexamethasone became globally critical after the RECOVERY trial. Each indication has specific dosing schedules and titration requirements, which is why manufacturers must guarantee consistent assay and uniform fill volume across every ampoule and vial.

Critical Quality Attributes for Dexamethasone Injection

Dexamethasone Sodium Phosphate is photosensitive and pH-sensitive. Quality manufacturers protect the API with amber glass primary packaging, nitrogen flushing to displace headspace oxygen, and tightly controlled pH (typically 7.0–8.5) using sodium phosphate buffer. Sterility is non-negotiable: terminal sterilization is generally not feasible due to drug degradation risk, so aseptic processing under ISO Class 5 cleanroom conditions is the standard route. Endotoxin testing per USP <85> and sterility testing per USP <71> are mandatory release tests.

Stability data must demonstrate at least 24 months shelf life under controlled storage conditions (typically 15–25 °C, protected from light). Particulate matter testing per USP <788>, container-closure integrity testing, and rigorous in-process pH/assay/clarity controls round out the quality attribute profile. A manufacturer that cannot provide this complete data package is not export-ready — full stop.

Looking for a trusted manufacturer? Submit a Quick Inquiry

Farbe Firma's Dexamethasone Injection Manufacturing Capability

Farbe Firma manufactures Dexamethasone Sodium Phosphate Injection in our purpose-built sterile facility in Ankleshwar, Gujarat. Our small-volume parenteral (SVP) line uses fully validated aseptic processing under ISO Class 5 laminar flow with continuous viable and non-viable particle monitoring. We fill into amber glass ampoules and vials sourced from approved Type-I primary packaging suppliers, with nitrogen overlay to extend stability and protect against oxidation. Every batch is released only after sterility, bacterial endotoxin, assay (HPLC), pH, particulate matter, and visual inspection passes — and every release is signed by qualified persons accountable under Schedule M and WHO-GMP standards.

Our quality control laboratory is equipped with HPLC, GC, dissolution testers, IR spectrophotometers, and a microbiology suite for sterility and endotoxin assays. Stability studies are conducted in ICH-compliant chambers covering long-term (25 °C/60% RH), accelerated (40 °C/75% RH), and intermediate (30 °C/65% RH) conditions, enabling robust shelf-life claims that hold up in any regulatory submission. For long-term partners, we offer customized labelling, multi-language artwork, and country-specific carton designs that meet local regulatory presentation requirements.

Why Farbe Firma

Farbe Firma Pvt Ltd is a WHO-GMP certified pharmaceutical injectable manufacturer headquartered in Gujarat, India. Our facility operates ISO Class 5 cleanrooms for aseptic processing, validated lyophilization lines, and high-speed vial and ampoule filling under continuous environmental monitoring. We currently manufacture 100+ injectables across corticosteroids, antibiotics, anti-infectives, oncology support, anesthesia, and critical care — and Dexamethasone Sodium Phosphate Injection is one of our flagship corticosteroid offerings.

Our export footprint spans 30+ countries across Africa, Southeast Asia, the Middle East, Latin America, and the CIS region. We support government tenders, hospital networks, and pharma distributors with consistent batch quality and complete regulatory documentation. Many partners have worked with us for over a decade — a tenure that reflects our predictable delivery, transparent communication, and commitment to compliance.

Our regulatory affairs team prepares dossiers in CTD and ACTD formats, supports product registration filings, manages post-approval variations and renewals, and delivers pharmacovigilance reporting where required. Combined with technical leadership from Maulik Sudani and Jignasu Sudani — both with deep experience in sterile manufacturing and regulatory affairs — Farbe Firma offers the technical depth and commercial reliability that global Dexamethasone Sodium Phosphate Injection buyers require.

Explore Farbe Firma: Products | Global Reach | About Us

Frequently Asked Questions

What strengths of Dexamethasone Sodium Phosphate Injection does Farbe Firma manufacture?

Farbe Firma manufactures Dexamethasone Sodium Phosphate Injection in 4 mg/mL and 8 mg/2 mL strengths, in 1 mL and 2 mL amber glass ampoules as well as 5 mL and 30 mL multi-dose vials. Custom strengths and pack sizes are available on request for tender-driven volumes.

Is your Dexamethasone Injection WHO-GMP certified?

Yes. Our Dexamethasone Sodium Phosphate Injection is manufactured under valid WHO-GMP certification, ISO 9001:2015 quality management, and Schedule M of the Indian Drugs and Cosmetics Act. Audits by buyers, distributors, and regulatory authorities are welcomed at our Ankleshwar facility.

Do you provide CTD or ACTD dossiers for product registration?

Yes. We provide complete CTD dossiers for ICH-aligned markets and ACTD dossiers for ASEAN-aligned markets, including full Module 3 quality data, stability summaries, validation reports, and the supportive documents needed for product registration in your target country.

What is the shelf life of your Dexamethasone Sodium Phosphate Injection?

Farbe Firma's Dexamethasone Sodium Phosphate Injection has a labelled shelf life of 24 months under recommended storage (15–25 °C, protected from light). This is supported by long-term, accelerated, and intermediate ICH-compliant stability data.

What is the minimum order quantity (MOQ) and typical lead time?

Standard MOQ is 50,000 ampoules or vials per SKU, though tender-driven larger volumes are routinely fulfilled. Lead time is typically 45–60 days from purchase order confirmation, including raw material procurement, manufacturing, QC release, and export documentation.

Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)

Farbe Firma Pvt Ltd | Website: www.farbefirma.org | Email: director@farbefirma.org | Gujarat, India

Request a Quote | View Products | FAQ | Blog